Braskem (BAK) Cost of Revenue (2009 - 2025)

Braskem (BAK) has reported Cost of Revenue for 16 consecutive years, with $3.1 billion the latest figure, recorded in Q1 2025.

• Quarterly Cost of Revenue changed N/A year-over-year to $3.1 billion in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $27.2 billion (changed N/A YoY) and the FY2025 annual result came in at $12.8 billion, up 4.39% from the prior year.
• Cost of Revenue fell to $3.1 billion in Q1 2025 per BAK's latest filing, from $17.2 billion in the prior quarter.
• Over the last five years, Cost of Revenue for BAK reached as high as $17.2 billion in Q4 2023 and fell as low as $3.1 billion in Q1 2025.
• A 4-year average of $5.9 billion and a median of $3.7 billion in 2021 frame the typical range for Cost of Revenue.
• The largest YoY upside for Cost of Revenue was 374.6% in 2023 against a maximum downside of 25.33% in 2023.
• Year by year, Cost of Revenue stood at $3.9 billion in 2021, then fell by 6.01% to $3.6 billion in 2022, then surged by 374.6% to $17.2 billion in 2023, then slumped by 81.99% to $3.1 billion in 2025.
• According to Business Quant data, Cost of Revenue over the past three periods registered $3.1 billion, $17.2 billion, and $3.3 billion for Q1 2025, Q4 2023, and Q3 2023 respectively.